Hematopoietic and Lymphoid System Neoplasm Clinical Trials

20 recruiting

Hematopoietic and Lymphoid System Neoplasm Trials at a Glance

20 actively recruiting trials for hematopoietic and lymphoid system neoplasm are listed on ClinicalTrialsFinder across 6 cities. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in Rochester, Scottsdale, and Duarte. Lead sponsors running hematopoietic and lymphoid system neoplasm studies include Mayo Clinic, City of Hope Medical Center, and M.D. Anderson Cancer Center.

Browse hematopoietic and lymphoid system neoplasm trials by phase

Treatments under study

About Hematopoietic and Lymphoid System Neoplasm Clinical Trials

Looking for clinical trials for Hematopoietic and Lymphoid System Neoplasm? There are currently 20 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic and Lymphoid System Neoplasm trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic and Lymphoid System Neoplasm clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 20 trials

Recruiting
Phase 2

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Advanced Colorectal CarcinomaAdvanced Anal CarcinomaAdvanced Biliary Tract Carcinoma+41 more
Mayo Clinic220 enrolled2 locationsNCT05969860
Recruiting
Not Applicable

A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic660 enrolled3 locationsNCT06198010
Recruiting

INTERogating Cancer for Etiology, Prevention and Therapy Navigation

Malignant Solid NeoplasmCancerHematopoietic and Lymphoid System Neoplasm+2 more
Mayo Clinic500 enrolled3 locationsNCT06008392
Recruiting
Not Applicable

Virtual Reality Intervention to Improve Psychological Symptom Burden for Cancer Patients Undergoing Treatment

Malignant Solid NeoplasmCancerHematopoietic and Lymphoid System Neoplasm+3 more
Mayo Clinic24 enrolled1 locationNCT07221409
Recruiting
Not Applicable

Communication Issues in Patient and Provider Discussions of Immunotherapy

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Emory University125 enrolled2 locationsNCT05873608
Recruiting
Phase 1Phase 2

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Acute Myeloid LeukemiaHematopoietic and Lymphoid System NeoplasmMyelodysplastic Syndrome+3 more
M.D. Anderson Cancer Center96 enrolled4 locationsNCT03471260
Recruiting

A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic10,000 enrolled1 locationNCT06192875
Recruiting
Phase 2

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center216 enrolled3 locationsNCT06059391
Recruiting

Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study

Chronic Lymphocytic LeukemiaHematopoietic and Lymphoid System NeoplasmMantle Cell Lymphoma+2 more
Mayo Clinic100 enrolled1 locationNCT06151730
Recruiting
Not Applicable

Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic60 enrolled1 locationNCT05584449
Recruiting
Phase 1Phase 2

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

Hematopoietic and Lymphoid System Neoplasm
M.D. Anderson Cancer Center25 enrolled1 locationNCT04022239
Recruiting
Not Applicable

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

Malignant Solid NeoplasmHematopoietic and Lymphoid System NeoplasmHereditary Malignant Neoplasm
City of Hope Medical Center240 enrolled1 locationNCT05772130
Recruiting
Not Applicable

Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic200 enrolled1 locationNCT06246955
Recruiting
Not Applicable

Community-Based Physical Activity Intervention for Underserved Cancer Survivors

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute200 enrolled1 locationNCT06206863
Recruiting
Not Applicable

Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients

Hematopoietic and Lymphoid System Neoplasm
Roswell Park Cancer Institute75 enrolled1 locationNCT05893940
Recruiting
Not Applicable

Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
City of Hope Medical Center216 enrolled3 locationsNCT06022965
Recruiting
Not Applicable

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic400 enrolled1 locationNCT06015932
Recruiting
Phase 1

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

Acute Graft Versus Host DiseaseHematopoietic and Lymphoid System Neoplasm
City of Hope Medical Center18 enrolled1 locationNCT05443425
Recruiting
Not Applicable

Outreach Project to Connect Underrepresented Populations to Clinical Trials at Ohio State University, CUSP2CT Project Trial

Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Ohio State University Comprehensive Cancer Center208 enrolled1 locationNCT06314672
Recruiting

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Metastatic Malignant Solid NeoplasmHematopoietic and Lymphoid System Neoplasm
Mayo Clinic50 enrolled1 locationNCT05530759